Therefore, the aforementioned results indicated that DPHB could improve glucose and lipid metabolism disorders and improve insulin sensitivity by regulating some of the adipokines (such as adiponectin, PPARγ, C/EBPα, and SREBP-1). The gene discussed is PPARG; the disease is Disorder of lipid metabolism.